Observational studyEuropean journal of pediatrics2023

NT-PROBNP as a screening tool for low-risk patent ductus arteriousus: a follow-up validation study.

Gloria López-Blanco et al.PubMed ↗Publisher ↗

No numbers read from the abstract.